Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $218B |
| FY2017, ended Dec 31, 2017 | $216B |
| FY2018, ended Dec 31, 2018 | $232B |
| FY2019, ended Dec 31, 2019 | $254B |
| FY2020, ended Dec 31, 2020 | $243B |
| FY2021, ended Dec 31, 2021 | $218B |
| FY2022, ended Dec 31, 2022 | $165B |
| FY2023, ended Dec 31, 2023 | $159B |
| FY2024, ended Dec 31, 2024 | $168B |
| FY2025, ended Dec 31, 2025 | $172B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $176B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $126B |
| FY2017, ended Dec 31, 2017 | $126B |
| FY2018, ended Dec 31, 2018 | $131B |
| FY2019, ended Dec 31, 2019 | $132B |
| FY2020, ended Dec 31, 2020 | $128B |
| FY2021, ended Dec 31, 2021 | $134B |
| FY2022, ended Dec 31, 2022 | $137B |
| FY2023, ended Dec 31, 2023 | $134B |
| FY2024, ended Dec 31, 2024 | $135B |
| FY2025, ended Dec 31, 2025 | $138B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $139B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $13.1B | $4.63B |
| FY2017, ended Dec 31, 2017 | $30.1B | $7.07B |
| FY2018, ended Dec 31, 2018 | $15.5B | $17.7B |
| FY2019, ended Dec 31, 2019 | $19.3B | $17.8B |
| FY2020, ended Dec 31, 2020 | $17.8B | $23.6B |
| FY2021, ended Dec 31, 2021 | $22.1B | $19.3B |
| FY2022, ended Dec 31, 2022 | $21.3B | $14.1B |
| FY2023, ended Dec 31, 2023 | $11.6B | $18.7B |
| FY2024, ended Dec 31, 2024 | $17.5B | $19.8B |
| FY2025, ended Dec 31, 2025 | $17.2B | $20.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $16.2B | $21.5B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.88B |
| FY2017, ended Dec 31, 2017 | $2.08B |
| FY2018, ended Dec 31, 2018 | $2.75B |
| FY2019, ended Dec 31, 2019 | $2.59B |
| FY2020, ended Dec 31, 2020 | $22.2B |
| FY2021, ended Dec 31, 2021 | $2.92B |
| FY2022, ended Dec 31, 2022 | $2.60B |
| FY2023, ended Dec 31, 2023 | $2.06B |
| FY2024, ended Dec 31, 2024 | $4.19B |
| FY2025, ended Dec 31, 2025 | $19.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.75B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $108B |
| FY2017, ended Dec 31, 2017 | $117B |
| FY2018, ended Dec 31, 2018 | $113B |
| FY2019, ended Dec 31, 2019 | $111B |
| FY2020, ended Dec 31, 2020 | $129B |
| FY2021, ended Dec 31, 2021 | $151B |
| FY2022, ended Dec 31, 2022 | $151B |
| FY2023, ended Dec 31, 2023 | $151B |
| FY2024, ended Dec 31, 2024 | $144B |
| FY2025, ended Dec 31, 2025 | $158B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $165B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 1.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.08B |
| FY2017, ended Dec 31, 2017 | 4.08B |
| FY2018, ended Dec 31, 2018 | 4.13B |
| FY2019, ended Dec 31, 2019 | 4.14B |
| FY2020, ended Dec 31, 2020 | 4.14B |
| FY2021, ended Dec 31, 2021 | 4.20B |
| FY2022, ended Dec 31, 2022 | 4.20B |
| FY2023, ended Dec 31, 2023 | 4.20B |
| FY2024, ended Dec 31, 2024 | 4.21B |
| FY2025, ended Dec 31, 2025 | 4.22B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 4.15B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $400M | $3.00M |
| FY2017, ended Dec 31, 2017 | $0 | — | — |
| FY2018, ended Dec 31, 2018 | — | — | — |
| FY2019, ended Dec 31, 2019 | — | — | — |
| FY2020, ended Dec 31, 2020 | — | — | — |
| FY2021, ended Dec 31, 2021 | — | — | — |
| FY2022, ended Dec 31, 2022 | — | — | — |
| FY2023, ended Dec 31, 2023 | — | — | — |
| FY2024, ended Dec 31, 2024 | — | — | — |
| FY2025, ended Dec 31, 2025 | — | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | — | — |
Valuation
At current price- Market Cap
- $183B
- P/E
- 11.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.3×
- Price / Book
- 1.7×
- EV / EBITDA
- 7.3×
Growth
Trailing 12 months- Revenue (TTM)
- $139B
- Revenue Growth YoY
- 1.4%
- Revenue CAGR 3Y
- 0.3%
- Revenue CAGR 5Y
- 1.5%
- EPS Growth YoY
- −10.7%
- Net Income Growth YoY
- −11.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 20.5%
- Net Margin
- 11.6%
- FCF Margin
- 15.5%
- Return on Equity
- 15.4%
Earnings
Trailing 12 months- Net Income
- $16.2B
- EPS (diluted)
- $3.84
- EBITDA
- $47.6B
- Operating Income
- $28.5B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.75B
- Total Debt
- $165B
- Net Debt
- $163B
- Total Assets
- $410B
- Total Liabilities
- $305B
- Shareholders' Equity
- $105B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $38.8B
- Capital Expenditure
- $17.3B
- Free Cash Flow
- $21.5B
Dividends and risk
Last 12 months- Dividend Yield
- 6.4%
- Dividend / Share
- $2.81
- Beta (5Y)
- 0.27
Every ratio is calculated from the company’s reported figures.